Briar Alpert Named to UVM Board of Trustees
News Mar 14, 2016
As part of this six-year term, Mr. Alpert will advise and support UVM management on policy, budgets, strategic planning and other matters to ensure the University’s long-term vision and success.
Mr. Alpert has far-reaching ties with the University, having earned his MBA and a BS in mechanical engineering from UVM. Additionally, his father and BioTek’s founder, Dr. Norman Alpert, was an internationally recognized expert in cardiac hypertrophy and energetics while serving as Chairman of the Physiology Department at the University of Vermont Medical College.
Along with the UVM Board of Trustees, Mr. Alpert is the Vice Chairman & Chairman-Elect for the Analytical, Life Science & Diagnostics Association (ALDA), a Charter Member and Director of the Vermont Center of Emerging Technologies (VCET), and is a full member of the Vermont Academy of Science and Engineering (VASE) and Mechanical Engineering Honor Society.
A New, Streamlined Approach to Diagnosing and Treating Bowel CancerNews
Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.READ MORE
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
New Rapid-fire Method Using Pathology Images & Tumor Data May Help Guide Cancer TherapiesNews
By combining data on pathology images of 13 types of cancer and correlating that with clinical and genomic data, researchers are able to identify tumor-infiltrating lymphocytes, which will enable cancer specialists to generate tumor-immune information from routinely gathered pathology slides.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018